HopeStage
Back to all studies
WithdrawnNCT05991232

Repeated Neurocognitive Measurements in Depressed Patients

Medication studyAges 18–60United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
ColumbusSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 1, 2025
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Jay Fournier
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT05991232
Official title
Show the full official title

Repeated Neurocognitive Measurements in Depressed Patients

Recruitment & locations

Withdrawn

Columbus

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Jay Fournier.

Does this study involve medication?

Yes. The study involves medication, including Intravenous Ketamine.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies